APA (7th ed.) Citation

KAN, S., KOIDO, S., OKAMOTO, M., HAYASHI, K., ITO, M., KAMATA, Y., . . . HOMMA, S. (2015). Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncology reports, 34(1), 504-510. https://doi.org/10.3892/or.2015.3974

Chicago Style (17th ed.) Citation

KAN, SHIN, et al. "Gemcitabine Treatment Enhances HER2 Expression in Low HER2-expressing Breast Cancer Cells and Enhances the Antitumor Effects of Trastuzumab Emtansine." Oncology Reports 34, no. 1 (2015): 504-510. https://doi.org/10.3892/or.2015.3974.

MLA (9th ed.) Citation

KAN, SHIN, et al. "Gemcitabine Treatment Enhances HER2 Expression in Low HER2-expressing Breast Cancer Cells and Enhances the Antitumor Effects of Trastuzumab Emtansine." Oncology Reports, vol. 34, no. 1, 2015, pp. 504-510, https://doi.org/10.3892/or.2015.3974.